Researchers at the University of Hong Kong have developed a novel nasal spray, NanoPowder, designed to deliver neurotherapeutic agents directly to the brain for rapid ischemic stroke treatment. This innovation, utilizing nano-in-micron technology to bypass the blood-brain barrier, aims to significantly reduce brain damage and improve survival rates. Clinical trials are anticipated by 2030, with potential applications for paramedics, high-risk groups, and eventually the general public. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
RANK_REASON Academic research from a university lab developing a novel therapeutic. [lever_c_demoted from research: ic=1 ai=0.0]
